Logo image of CGRN

CAPSTONE GREEN ENERGY CORP (CGRN) Stock Fundamental Analysis

NASDAQ:CGRN - US14067D5086 - Common Stock

0.37 USD
+0.06 (+19.35%)
Last: 10/4/2023, 8:00:00 PM
0.3011 USD
-0.07 (-18.62%)
After Hours: 10/4/2023, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CGRN. CGRN was compared to 93 industry peers in the Electrical Equipment industry. CGRN has a bad profitability rating. Also its financial health evaluation is rather negative. CGRN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CGRN has reported negative net income.
CGRN had a negative operating cash flow in the past year.
In the past 5 years CGRN always reported negative net income.
CGRN had negative operating cash flow in 4 of the past 5 years.
CGRN Yearly Net Income VS EBIT VS OCF VS FCFCGRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

CGRN has a worse Return On Assets (-18.29%) than 61.36% of its industry peers.
The Return On Equity of CGRN (-1757.75%) is worse than 90.91% of its industry peers.
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROIC N/A
ROA(3y)-22.38%
ROA(5y)-21.03%
ROE(3y)-227.41%
ROE(5y)-158.59%
ROIC(3y)N/A
ROIC(5y)N/A
CGRN Yearly ROA, ROE, ROICCGRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

CGRN has a Gross Margin (14.06%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CGRN has grown nicely.
CGRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y39.37%
CGRN Yearly Profit, Operating, Gross MarginsCGRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 -20 -30

0

2. Health

2.1 Basic Checks

CGRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CGRN has more shares outstanding
CGRN has a worse debt/assets ratio than last year.
CGRN Yearly Shares OutstandingCGRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
CGRN Yearly Total Debt VS Total AssetsCGRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -12.69, we must say that CGRN is in the distress zone and has some risk of bankruptcy.
CGRN has a Altman-Z score of -12.69. This is amonst the worse of the industry: CGRN underperforms 94.32% of its industry peers.
A Debt/Equity ratio of 49.90 is on the high side and indicates that CGRN has dependencies on debt financing.
CGRN has a Debt to Equity ratio of 49.90. This is amonst the worse of the industry: CGRN underperforms 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF N/A
Altman-Z -12.69
ROIC/WACCN/A
WACC8.69%
CGRN Yearly LT Debt VS Equity VS FCFCGRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M

2.3 Liquidity

CGRN has a Current Ratio of 0.70. This is a bad value and indicates that CGRN is not financially healthy enough and could expect problems in meeting its short term obligations.
CGRN's Current ratio of 0.70 is on the low side compared to the rest of the industry. CGRN is outperformed by 92.05% of its industry peers.
A Quick Ratio of 0.42 indicates that CGRN may have some problems paying its short term obligations.
The Quick ratio of CGRN (0.42) is worse than 92.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.42
CGRN Yearly Current Assets VS Current LiabilitesCGRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

4

3. Growth

3.1 Past

CGRN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.58%.
Looking at the last year, CGRN shows a small growth in Revenue. The Revenue has grown by 4.24% in the last year.
The Revenue has been decreasing by -2.04% on average over the past years.
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.87%

3.2 Future

CGRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.33% yearly.
CGRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.71% yearly.
EPS Next Y18.64%
EPS Next 2Y34.55%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year4.45%
Revenue Next 2Y7.35%
Revenue Next 3Y6.56%
Revenue Next 5Y27.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGRN Yearly Revenue VS EstimatesCGRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
CGRN Yearly EPS VS EstimatesCGRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10

1

4. Valuation

4.1 Price/Earnings Ratio

CGRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CGRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGRN Price Earnings VS Forward Price EarningsCGRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGRN Per share dataCGRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CGRN's earnings are expected to grow with 25.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.55%
EPS Next 3Y25.33%

0

5. Dividend

5.1 Amount

CGRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPSTONE GREEN ENERGY CORP

NASDAQ:CGRN (10/4/2023, 8:00:00 PM)

After market: 0.3011 -0.07 (-18.62%)

0.37

+0.06 (+19.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)09-25 2023-09-25/amc
Earnings (Next)11-13 2023-11-13/amc
Inst Owners19.26%
Inst Owner ChangeN/A
Ins Owners3.43%
Ins Owner Change0%
Market Cap6.79M
Analysts43.33
Price Target1.58 (327.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.29%
Min EPS beat(2)-110.08%
Max EPS beat(2)-52.51%
EPS beat(4)1
Avg EPS beat(4)-43.37%
Min EPS beat(4)-110.08%
Max EPS beat(4)49.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.62%
Min Revenue beat(2)-14.57%
Max Revenue beat(2)1.33%
Revenue beat(4)1
Avg Revenue beat(4)-11.74%
Min Revenue beat(4)-31.49%
Max Revenue beat(4)1.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-90%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 6.22
P/tB 6.22
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS4.08
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.29%
ROE -1757.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.06%
FCFM N/A
ROA(3y)-22.38%
ROA(5y)-21.03%
ROE(3y)-227.41%
ROE(5y)-158.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y39.37%
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 49.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 279.68%
Cap/Sales 10.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.42
Altman-Z -12.69
F-Score4
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)333.04%
Cap/Depr(5y)283.07%
Cap/Sales(3y)8.37%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
EPS Next Y18.64%
EPS Next 2Y34.55%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue 1Y (TTM)4.24%
Revenue growth 3Y-5.83%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.87%
Revenue Next Year4.45%
Revenue Next 2Y7.35%
Revenue Next 3Y6.56%
Revenue Next 5Y27.71%
EBIT growth 1Y37.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.73%
EBIT Next 3Y38.22%
EBIT Next 5Y33.09%
FCF growth 1Y-128.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.91%
OCF growth 3YN/A
OCF growth 5YN/A